dc.contributor.author | Emekli, Ahmed Serkan | |
dc.date.accessioned | 2021-03-03T20:20:05Z | |
dc.date.available | 2021-03-03T20:20:05Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Emekli A. S. , "Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis", TURKISH JOURNAL OF NEUROLOGY, cilt.23, sa.3, ss.148-149, 2017 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_595760e8-e7e0-4380-ab97-76c47a5848df | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/62860 | |
dc.identifier.uri | https://doi.org/10.4274/tnd.90018 | |
dc.language.iso | eng | |
dc.subject | Nöroloji | |
dc.subject | Tıp | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.title | Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis | |
dc.type | Makale | |
dc.relation.journal | TURKISH JOURNAL OF NEUROLOGY | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 23 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 148 | |
dc.identifier.endpage | 149 | |
dc.contributor.firstauthorID | 245089 | |